Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Vertex Pharma profit tops estimates on strong launch of new CF drug

      Vertex Pharma profit tops estimates on strong launch of new CF drug

      Ruby Khatun Khatun28 April 2018 9:30 AM IST
      Vertex Pharmaceuticals Inc topped analysts’ forecasts for quarterly profit, led by stronger-than-expected sales of its latest cystic fibrosis drug as...
      Abbott discontinues Xience Alpine stents in India

      Abbott discontinues Xience Alpine stents in India

      Ruby Khatun Khatun27 April 2018 12:04 PM IST
      New Delhi: Healthcare firm Abbott today said it has fulfilled all the requirements to discontinue its Xience Alpine drug-eluting stent in India and...
      Zydus Cadila gets USFDA nod to market 2 drugs

      Zydus Cadila gets USFDA nod to market 2 drugs

      Ruby Khatun Khatun27 April 2018 10:45 AM IST
      New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market two drugs used for the treatment of...
      Binding bids: Fortis Healthcare board to meet again today

      Binding bids: Fortis Healthcare board to meet again today

      Ruby Khatun Khatun27 April 2018 10:32 AM IST
      New Delhi: A meeting of Fortis Healthcare board yesterday remained inconclusive on the binding bids by the likes of Malaysian firm IHH Healthcare,...
      Nayati Healthcare acquires majority stake in Gurgaon, Delhi Hospitals

      Nayati Healthcare acquires majority stake in Gurgaon, Delhi Hospitals

      Ruby Khatun Khatun27 April 2018 10:02 AM IST
      New Delhi: After successfully bringing multi super specialty healthcare services to the millions living in Uttar Pradesh, Nayati Healthcare announces...
      Cabinet approves MoU with BRICS nations for regulation of medical products for human use

      Cabinet approves MoU with BRICS nations for regulation of medical products for human use

      Ruby Khatun Khatun27 April 2018 10:00 AM IST
      New Delhi: The government gave its nod to the signing of a pact with medicine regulatory agencies of BRICS nations on cooperation in the field of...
      Novartis digital drive continues with eye-disease app

      Novartis digital drive continues with eye-disease app

      Ruby Khatun Khatun27 April 2018 9:45 AM IST
      ZURICH: Novartis’s foray into digital technology intensified as the Swiss drugmaker launched a mobile-phone based app to help collect data from people...
      US court upholds dismissal of 200 million dollars Merck verdict against Gilead

      US court upholds dismissal of 200 million dollars Merck verdict against Gilead

      Ruby Khatun Khatun27 April 2018 9:30 AM IST
      A U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
      Ban selling, import of smokeless tobacco products: NICPR-ICMR report

      Ban selling, import of smokeless tobacco products: NICPR-ICMR report

      Ruby Khatun Khatun26 April 2018 4:09 PM IST
      New Delhi: A government body along with the Indian Council of Medical Research (ICMR) has compiled a report that recommends banning the manufacture,...
      Strides Shasun to divest API arm to Solara for Rs 131 crore

      Strides Shasun to divest API arm to Solara for Rs 131 crore

      Ruby Khatun Khatun26 April 2018 10:45 AM IST
      New Delhi: Drug firm Strides Shasun said its board has approved a proposal to divest its entire shareholding in Strides Chemicals to Mumbai-based...
      USFDA completes inspection at Alembic Pharma’s Panelav plant

      USFDA completes inspection at Alembic Pharma’s Panelav plant

      Ruby Khatun Khatun26 April 2018 10:30 AM IST
      New Delhi: Drug major Alembic Pharmaceuticals said the US health regulator has conducted an inspection at its Panelav facility and has not made any...
      Cabinet approves MoU between India, African nation in medicinal plants sector

      Cabinet approves MoU between India, African nation in medicinal plants sector

      Ruby Khatun Khatun26 April 2018 10:15 AM IST
      New Delhi: The government gave an ex-post facto approval for an agreement signed between India and an African island nation, Sao Tome and Principe, to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok